Zobrazeno 1 - 10
of 26
pro vyhledávání: '"S. A. Goryacheva"'
Autor:
O. N. Goryacheva, S. A. Goryacheva
Publikováno v:
Вестник университета, Vol 0, Iss 2, Pp 179-185 (2020)
Influence of the media on the market of biotechnological products has been studied. Awareness of citizens about food technologies and genetically modified foods has been analysed. Position of state institutions and the scientific community regarding
Externí odkaz:
https://doaj.org/article/bfd0ccca0a634c558ab23232b9144948
Publikováno v:
Архивъ внутренней медицины, Vol 9, Iss 4, Pp 313-315 (2019)
The article presents a clinical case of an onset of antiphospholipid syndrome in a patient with systemic lupus erythematosus and ischemic stroke. Systemic lupus erythematosus is a non-modifiable risk factor for ischemic stroke.
Externí odkaz:
https://doaj.org/article/3032a9e3a0c24bb49a1eff4e4ebfd5f7
Autor:
T. T. Valiev, A. A. Khachatryan, S. V. Goryacheva, N. A. Batmanova, K. I. Kirgizov, S. R. Varfolomeeva
Publikováno v:
Онкогематология, Vol 19, Iss 1, Pp 40-50 (2024)
The use of high-effective, multicomponent, risk-adopted chemoimmunotherapy schemes in children with Burkitt lymphoma reached advanced long-term progression-free survival over 90 % even for high risk patients. Unfortunately, conventional therapeutic s
Externí odkaz:
https://doaj.org/article/3c78d79e364b4d8d9aebc4aac47983aa
Autor:
K. I. Utesheva, T. T. Valiev, O. A. Ignatenko, S. V. Goryacheva, N. A. Batmanova, K. I. Kirgizov
Publikováno v:
Онкогематология, Vol 18, Iss 1, Pp 121-125 (2023)
Immunotherapy is a promising method in the treatment of cancer. PD-1 (programmed cell death protein 1) receptor and its ligand, which contribute to the reactivation of T-cells exerting their cytotoxic function against the tumor, are one of the target
Externí odkaz:
https://doaj.org/article/f9a3de2ac33446b593dae4f6bc1daa35
Autor:
A G Turkina, E Yu Chelysheva, V A Shuvaev, G A Gusarova, A V Bykova, O A Shukhov, A N Petrova, M V Vakhrusheva, S R Goryacheva, L Yu Kolosova, P S Krasikova, M S Fominykh, I S Martynkevich, A O Abdullaev, A B Sudarikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 12, Pp 86-96 (2017)
Aim. To assess the results of following up patients with chronic myeloid leukemia (CML) and a deep molecular response (MR) without tyrosine kinase inhibitor (TKI) therapy. Subjects and methods. The reasons for TKI discontinuation in 70 patients with
Externí odkaz:
https://doaj.org/article/a5d61a4d5cc34f2caccd0b415e5af767
Autor:
T N Moiseeva, L S Al-radi, A M Kovrigina, S R Goryacheva, U L Julakyan, O V Margolin, N I Skidan, M A Tseytlina, S K Kravchenko
Publikováno v:
Терапевтический архив, Vol 87, Iss 11, Pp 78-83 (2015)
Aim. To describe the clinical and morphological features of the rare Hodgkin’s lymphoma (HL) subtype — nodular lymphocyte-predominant HL (NLPHL). Subjects and methods. Forty-two patients were diagnosed with NLPHL in 2010 to 2014. The male to fema
Externí odkaz:
https://doaj.org/article/1f2616a56a354f56aa50532daa7e8416
Autor:
O. Yu. Vinogradova, E. A. Aseeva, A. V. Vorontsova, A. G. Turkina, A. L. Neverova, O. V. Lazareva, E. Yu. Chelysheva, G. A. Gusarova, T. I. Kolosheinova, L. Yu. Kolosova, S. R. Goryacheva, M. V. Vakhrusheva, S. M. Kulikov, I. A. Tishchenko, L. V. Dyachenko, A. I. Udovichenko, G. A. Alimova, E. V. Kleina, L. A. Grebenyuk, M. L. Konnova, S. Yu. Smirnova, N. D. Khoroshko, E. V. Domracheva
Publikováno v:
Онкогематология, Vol 7, Iss 4, Pp 24-34 (2014)
The additional molecular and chromosomal abnormalities (ACA) in Phositive cells usually considered as a genetic marker of chronic myeloid leukemia (CML) progression. 457 patients in different CML phases received tyrosine kinase inhibitors (1st and 2n
Externí odkaz:
https://doaj.org/article/32cda5ba2fdf4d37889b2dd716f62b03
Publikováno v:
Onkogematologiâ, Vol 16, Iss 2, Pp 40-47 (2021)
Cytopenia commonly occurs in case of chronic lymphocytic leukemia. It can either precede the diagnosis of chronic lymphocytic leukemia or appear at any time during the disease. Autoimmune hemolytic anemia, immune thrombocytopenia, and partial red cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc99cfbfe992c4b60d483a8f487da56e
https://oncohematology.abvpress.ru/ongm/article/view/473
https://oncohematology.abvpress.ru/ongm/article/view/473
Autor:
G A Gusarova, A G Turkina, E V Domracheva, L Yu Tikhonova, M O Egorova, T I Kolosheynova, O V Stakhina, I S Nemchenko, M V Vakhrusheva, E Yu Chelysheva, E S Zakharova, S R Goryacheva, M A Sokolova, S V Kuznetsov, N A Afanas'eva, N D Khoroshko
Publikováno v:
Современная онкология, Vol 12, Iss 1, Pp 38-42 (2010)
Externí odkaz:
https://doaj.org/article/2378899bf7fc419d80c98cdefa5a74c9
Autor:
Anna Grigor'evna Turkina, Elena Vasil'evna Domracheva, Aleksandra Valer'evna Vorontsova, Elena Aleksandrovna Aseeva, Ol'ga Yur'evna Vinogradova, Ol'ga Veniaminovna Stakhina, Galina Anatol'evna Gusarova, Ol'ga Arkad'evna Dyagileva, Elena Aleksandrovna Semenova, Marina Vasil'evna Vakhrusheva, Tamara Ivanovna Kolosheynova, Evgeniy Mikhaylovich Abakumov, Ekaterina Yur'evna Chelysheva, Svetlana Rudol'fovna Goryacheva, Tat'yana Vladimirovna Ivanova, Elena Stanislavovna Zakharova, Lyubov' Yur'evna Kolosova, Adel' Vladimirovna Zakharova, Irina Nikolaevna Naumova, Larisa Vladimirovna Dyachenko, Sergey Mikhaylovich Kulikov, Lidiya Grigor'evna Kovaleva, Nina Dmitrievna Khoroshko, A G Turkina, E V Domracheva, A V Vorontsova, E A Aseeva, O Yu Vinogradova, O V Stakhina, G A Gusarova, O A Dyagileva, E A Semenova, M V Vakhrusheva, T I Kolosheinova, E M Abakumov, E Yu Chelysheva, S R Goryacheva, T V Ivanova, E S Zakharova, L Yu Kolosova, A V Zakharova, I N Naumova, L V Dyachenko, S M Kulikov, L G Kovaleva, N D Khoroshko
Publikováno v:
Терапевтический архив, Vol 81, Iss 7, Pp 29-36 (2009)
Aim. To analyse clinical implications of chromosome 8 trisomy in Ph-negative cells of the bone marrow in patients with chronic myeloid leukemia (CML) treated with inhibitors of tyrosinkinases (ITK). Material and methods. A total of 386 patients with
Externí odkaz:
https://doaj.org/article/ede8cfd0b762457a94075ebaf7be705f